Skip to main content
Figure 4 | Journal of Translational Medicine

Figure 4

From: A human model of inflammatory cardio-metabolic dysfunction; a double blind placebo-controlled crossover trial

Figure 4

Endotoxemia led to a systemic insulin resistant state as shown by (A) a decrease in the insulin sensitivity index (S i ) at FSIGT testing (placebo 3.31 ± 0.62 vs LPS 2.60 ± 0.63 (μU/ml)- 1·min-1, * p < 0.05, n = 5. Consistent with this decrease in insulin sensitivity, endotoxemia increased (B) HOMA-IR compared to placebo (*p < 0.05, n = 5).

Back to article page